What are the causes of tachycardia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Tachycardia

Tachycardia (heart rate >100 bpm) is caused by a wide range of physiological, pathological, and pharmacological factors, with the most common pathological causes including pyrexia, hypovolemia, anemia, and infections. 1

Classification of Tachycardias

Tachycardias can be broadly classified into:

1. Sinus Tachycardia

  • Physiological causes:

    • Physical exertion
    • Emotional stress and anxiety
    • Pain
    • Pregnancy
  • Pathological causes: 1

    • Fever/pyrexia
    • Hypovolemia
    • Anemia
    • Infections
    • Hypoxia
    • Acidosis
    • Thyroid disorders (hyperthyroidism)
    • Heart failure
  • Pharmacological causes: 1

    • Stimulants (caffeine, alcohol, nicotine)
    • Prescribed medications (salbutamol, aminophylline, atropine, catecholamines)
    • Recreational/illicit drugs (amphetamines, cocaine, ecstasy, cannabis)
    • Anticancer treatments (particularly anthracyclines like doxorubicin and daunorubicin)

2. Supraventricular Tachycardias (SVTs)

  • Atrioventricular nodal reentrant tachycardia (AVNRT) 2, 3
  • Atrioventricular reentrant tachycardia (AVRT) including Wolff-Parkinson-White syndrome 2, 3
  • Atrial tachycardia 3
  • Atrial flutter
  • Atrial fibrillation
  • Sinus node reentrant tachycardia 1
  • Postural orthostatic tachycardia syndrome (POTS) 1

3. Ventricular Tachycardias (VTs)

  • Structural heart disease: 4

    • Coronary artery disease/myocardial infarction
    • Dilated cardiomyopathy
    • Hypertrophic cardiomyopathy
    • Arrhythmogenic right ventricular cardiomyopathy (ARVC)
    • Valvular heart disease
    • Congenital heart disease
  • Primary electrical disorders: 4

    • Long QT syndrome
    • Short QT syndrome
    • Brugada syndrome
    • Catecholaminergic polymorphic ventricular tachycardia
  • Other causes:

    • Electrolyte abnormalities (hypokalemia, hypomagnesemia)
    • Drug toxicity (particularly digitalis) 1
    • Idiopathic VT (no detectable cause) 4

Clinical Presentation

Tachycardias often present with: 2, 5

  • Palpitations (including pulsation in the neck)
  • Chest pain
  • Lightheadedness or dizziness
  • Dyspnea (shortness of breath)
  • Diaphoresis (sweating)
  • Syncope (fainting)
  • In severe cases, sudden cardiac death 5

Complications

Persistent tachycardia can lead to:

  • Tachycardia-induced cardiomyopathy 6
  • Heart failure 6
  • Neurological complications 5
  • Hemodynamic instability 7

Diagnostic Approach

The American College of Cardiology and American Heart Association recommend: 7

  • 12-lead ECG assessment (essential for diagnosing the specific type of tachycardia)
  • Laboratory evaluation including:
    • Complete blood count (to identify anemia)
    • Basic metabolic panel (for electrolyte abnormalities)
    • Thyroid function tests
    • Toxicology screen when appropriate

Management Considerations

The approach to management depends on:

  1. Hemodynamic stability of the patient 7
  2. Type of tachycardia
  3. Underlying cause

For hemodynamically unstable patients, immediate synchronized cardioversion is recommended 7.

For stable patients with SVT, vagal maneuvers followed by adenosine are first-line treatments 7, 3.

Long-term management may include:

  • Treatment of underlying causes
  • Beta-blockers or calcium channel blockers 7, 3
  • Antiarrhythmic medications
  • Catheter ablation for recurrent episodes 7, 3

Important Caveats

  • Tachycardia is often misdiagnosed as anxiety or panic disorder, leading to delayed diagnosis 2
  • Verapamil should never be used in wide-complex tachycardia due to risk of hemodynamic deterioration 7
  • In patients with Wolff-Parkinson-White Syndrome and atrial fibrillation, verapamil, diltiazem, and adenosine should be avoided 7
  • Tachycardia-induced heart failure is potentially reversible with appropriate treatment of the underlying arrhythmia 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Supraventricular tachycardia: An overview of diagnosis and management.

Clinical medicine (London, England), 2020

Research

Tachyarrhythmias and neurologic complications.

Handbook of clinical neurology, 2021

Research

Tachycardia-induced heart failure.

The Permanente journal, 2007

Guideline

Cardiac Arrhythmia Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.